VMD Relative Valuation
VMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VMD is overvalued; if below, it's undervalued.
Historical Valuation
Viemed Healthcare Inc (VMD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 11.88 is considered Undervalued compared with the five-year average of 26.33. The fair price of Viemed Healthcare Inc (VMD) is between 9.39 to 16.58 according to relative valuation methord. Compared to the current price of 6.70 USD , Viemed Healthcare Inc is Undervalued By 28.62%.
Relative Value
Fair Zone
9.39-16.58
Current Price：6.70
28.62%
Undervalued
11.90
PE
1Y
3Y
5Y
Trailing
Forward
3.90
EV/EBITDA
Viemed Healthcare Inc. (VMD) has a current EV/EBITDA of 3.90. The 5-year average EV/EBITDA is 6.89. The thresholds are as follows: Strongly Undervalued below 2.06, Undervalued between 2.06 and 4.48, Fairly Valued between 9.31 and 4.48, Overvalued between 9.31 and 11.72, and Strongly Overvalued above 11.72. The current Forward EV/EBITDA of 3.90 falls within the Undervalued range.
10.00
EV/EBIT
Viemed Healthcare Inc. (VMD) has a current EV/EBIT of 10.00. The 5-year average EV/EBIT is 19.62. The thresholds are as follows: Strongly Undervalued below 3.55, Undervalued between 3.55 and 11.59, Fairly Valued between 27.66 and 11.59, Overvalued between 27.66 and 35.70, and Strongly Overvalued above 35.70. The current Forward EV/EBIT of 10.00 falls within the Undervalued range.
0.82
PS
Viemed Healthcare Inc. (VMD) has a current PS of 0.82. The 5-year average PS is 1.62. The thresholds are as follows: Strongly Undervalued below 0.40, Undervalued between 0.40 and 1.01, Fairly Valued between 2.23 and 1.01, Overvalued between 2.23 and 2.84, and Strongly Overvalued above 2.84. The current Forward PS of 0.82 falls within the Undervalued range.
0.00
P/OCF
Viemed Healthcare Inc. (VMD) has a current P/OCF of 0.00. The 5-year average P/OCF is 3.90. The thresholds are as follows: Strongly Undervalued below -4.29, Undervalued between -4.29 and -0.20, Fairly Valued between 7.99 and -0.20, Overvalued between 7.99 and 12.09, and Strongly Overvalued above 12.09. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Viemed Healthcare Inc. (VMD) has a current P/FCF of 0.00. The 5-year average P/FCF is 11.77. The thresholds are as follows: Strongly Undervalued below -12.31, Undervalued between -12.31 and -0.27, Fairly Valued between 23.81 and -0.27, Overvalued between 23.81 and 35.84, and Strongly Overvalued above 35.84. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Viemed Healthcare Inc (VMD) has a current Price-to-Book (P/B) ratio of 1.92. Compared to its 3-year average P/B ratio of 2.66 , the current P/B ratio is approximately -27.69% higher. Relative to its 5-year average P/B ratio of 2.80, the current P/B ratio is about -31.21% higher. Viemed Healthcare Inc (VMD) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.20%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.59% , the current FCF yield is about -100.00% lower.
1.93
P/B
Median3y
2.66
Median5y
2.80
2.10
FCF Yield
Median3y
2.20
Median5y
2.59
Competitors Valuation Multiple
The average P/S ratio for VMD's competitors is 0.00, providing a benchmark for relative valuation. Viemed Healthcare Inc Corp (VMD) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 23.98%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of VMD decreased by 15.59% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 58.00M to 71.91M.
The secondary factor is the P/E Change, contributed -14.01%to the performance.
Overall, the performance of VMD in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Viemed Healthcare Inc (VMD) currently overvalued or undervalued?
What is Viemed Healthcare Inc (VMD) fair value?
How does VMD's valuation metrics compare to the industry average?
What is the current P/B ratio for Viemed Healthcare Inc (VMD) as of Dec 05 2025?
What is the current FCF Yield for Viemed Healthcare Inc (VMD) as of Dec 05 2025?
What is the current Forward P/E ratio for Viemed Healthcare Inc (VMD) as of Dec 05 2025?